Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

Measuring hair glucocorticoids for stress is moderately feasible, especially in females and those with moderate intellectual disabilities.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The new tool helps measure the impact of alopecia areata on children's quality of life.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

Telogen effluvium most affects quality of life in alopecia patients.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Disease-specific tools better assess quality of life in alopecia areata patients.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

A new tool helps lupus patients and doctors better track symptoms and quality of life.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Lupus severely affects daily life, work, and mental health, with many experiencing frequent flares and medication side-effects.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

AGA patients have a lower quality of life than AA patients.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

Alopecia negatively affects quality of life and mental health.

Alopecia areata greatly affects the quality of life for children and their families.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.